GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
Worldwide growth in the biosimilars market is hitting its tipping point, analysts say. Sales are projected to hit $25 billion by 2020, according to the folks over at BioWorld who put together a new report, “Biosimilars: A Global Perspective of a New Market.” This is pretty impressive projected growth, considering that total global sales of drugs approved […]
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.